Glenmark Pharma Receives 2Nd Us Fda Tentative Approval For Generic Onglyza Tablets

Glenmark Pharmaceuticals Inc., Usa (Glenmark) Has Received A 2Nd Tentative Approval By The United States Food & Drug Administration (Fda) For Saxagliptin Tablets, 2.5 Mg And 5 Mg, The Generic Version Of Onglyza Tablets, 2.5 Mg And 5 Mg, Of Astrazeneca Ab. Glenmark